EZH2-mediated promoter hypermethylation represses FBP1, while FBP1 itself inhibits PRC2 activity through direct interaction with EZH2—a tumor-suppressive feedback loop disrupted by genotoxic agents that stabilize EZH2. This evidence concerns the gene EZH2 and neoplasm.